CClinicalTrials.gg
Status unknownNCT05575596Updated Mar 21, 2023

Influence of Social Deprivation and Remoteness on Quality of Life in Adolescent's Surgical Scoliosis

An observational study in Idiopathic Scoliosis, sponsored by University Hospital, Caen. Status unknown at 1 site in France. Open to participants aged 10 Years to 25 Years. Per ClinicalTrials.gov, last updated 2023-03-21.

Sponsored by University Hospital, Caen · Observational

The sponsor has not verified this record recently (last verified Mar 2023), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
250
Ages
10 Years to 25 Years
Sex
All
01

Study summary

The incidence of idiopathic scoliosis is 3% or approximatively 300,000 new cases per year in France. It is estimated that between 0.1 and 0.3% of patients will eventually require surgical management, between 500 and 1000 scoliosis are operated per year in France. To our knowledge, the impact of socio-economic and territorial inequalities on the quality of life before and after surgery of idiopathic scoliosis has not been studied previously.

Main objective:

-Assess the impact of socio-economic and territorial inequalities on the pre- and post-operative quality of life at 1 year after surgical idiopathic scoliosis management, in a French pediatric surgery multicenter cohort.

Secondary objective:

  • Assess the impact of socio-economic and territorial inequalities on the quality of life pre and postoperative at 3 months after surgery on a French multicenter cohort.
  • To assess the impact of severity and type of scoliosis on pre- and post-operative quality of life at 3 months and 1 year after surgery on a French multicenter cohort.
02

Conditions studied

  • Idiopathic Scoliosis

Browse trials for

Keywords

  • inequality
  • remoteness
  • socio economic
03

In context

Scoliosis

593 studies on the registry are indexed under Scoliosis; 138 are open to participants now.

This study's planned enrollment of 250 is above the median of 87 across 232 observational studies indexed under Scoliosis.

Browse Scoliosis studies →

Lead sponsor

University Hospital, Caen is the lead sponsor of 505 studies on the registry; 80 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
10 Years to 25 Years
Sexes eligible
All
Sampling method
Probability sample

Study population

All patients operated in one of the participating pediatric surgery center (Paris centers : NECKER and Robert DEBRE, University Hospital of Caen, University Hospital of Amiens, University Hospital of ROUEN, University Hospital of LILLE). Only the patient operated by posterior vertebral arthrodesis will be included.

Inclusion criteria

  • Operated by posterior vertebral arthrodesis
  • Opereted in pediatric surgery center
  • Idiopathic scoliosis treated by surgery

Exclusion criteria

Exclusion Criteria:

  • Refusal to participate
  • People unable to read or speak French (the questionnaire being in French)
  • Non-idiopathic scoliosis
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
250 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Change from baseline quality of life (SRS-22) at one year after surgery depending on the socio-economic level and remoteness.

    We will use the SRS-22 questionnaire, a specific questionnaire validated in French to assess the quality of life of patients with scoliosis. The questionnaire coverts different part of socio-economic levels including the salary, the educational level, the type of social security coverage, the parents' family situation (single parent, two-parent, blended couple) and the number of people and pieces in the habitation. The remoteness will be evaluated by the distance between the medical referent center and the habitation.

    Time frame: At 1 years after surgery. Baseline questionnaire will be assessed just before the surgery

Secondary outcomes

  1. Radiological data: angulation parameters

    Scoliosis radiological parameters before and after surgery (just after and at 1 year after surgery) cobb, kyphosis, lordosis, pelvic incidence (unit of measure: angulation in degrees)

    Time frame: at the time of surgery and at one year fater surgery

  2. Radiological data : type of scoliosis

    Scoliosis radiological parameters before and after surgery (just after and at 1 year after surgery): type of scoliosis (lenkee classification)

    Time frame: at the time of surgery and at one year fater surgery

  3. Clinical data: age

    Age at diagnosis and at surgery in months

    Time frame: at the surgery

  4. Clinical data: weight

    weight (in kilograms)

    Time frame: at the surgery

  5. Clinical data: previous treatments

    previous treatment for scoliosis (yes or no)

    Time frame: at the surgery

  6. Clinical data: family history

    history of scoliosis in the family (yes or no)

    Time frame: at the surgery

  7. Surgery data

    Type of instrumentation, level of instrumentation, surgical complications (neurological, infectious).

    Time frame: during the firts year after the surgery

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 21, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05575596
Lead sponsor
University Hospital, Caen
Collaborators
Hôpital Necker-Enfants Malades, Hopital Universitaire Robert-Debre, Amiens University Hospital, University Hospital, Rouen, University Hospital, Lille
Responsible party
Nathan DOLET (MD, University Hospital, Caen) — Principal investigator
First posted
Oct 12, 2022
Start date
Nov 14, 2022
Primary completion
Nov 2024 (estimated)
Completion
Nov 2024 (estimated)
Last update
Mar 21, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion